Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

NCT02253407 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Response to MMR Vaccine

Interventions

BIOLOGICAL: MMR vaccine

Sponsor

Serum Institute of India Pvt. Ltd.

Collaborators

[object Object]